Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia: A case report

BACKGROUND: Hereditary hemorrhagic telangiectasia is an inherited autosomal dominant disease presenting with recurrent bleeding episodes and iron deficiency anemia due to vascular malformations. Hereditary hemorrhagic telangiectasia is associated with an increased risk of stroke, gastrointestinal bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Huemer, Florian, Dejaco, Martin, Grabmer, Christoph, Melchardt, Thomas, Neureiter, Daniel, Mayer, Georg, Egle, Alexander, Greil, Richard, Weiss, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318479/
https://www.ncbi.nlm.nih.gov/pubmed/27878613
http://dx.doi.org/10.1007/s00508-016-1124-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318479/
https://www.ncbi.nlm.nih.gov/pubmed/27878613
http://dx.doi.org/10.1007/s00508-016-1124-4

Ejemplares similares